Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option Life Science Investing
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors Life Science Investing
Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors Life Science Investing
Relay Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights on February 26, 2026 Life Science Investing
Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications Life Science Investing
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference Life Science Investing
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec in Localized Prostate Cancer Life Science Investing
Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss? Life Science Investing